Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Stewart

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Future Oncology (London, England)|May 17, 2011
Carfilzomib: a novel second-generation proteasome inhibitorMeaghan L Khan, A Keith Stewart
International Journal of Biochemistry and Molecular Biology|October 18, 2011
What is the functional role of the thalidomide binding protein cereblon?Xiu-Bao Chang, A Keith Stewart
Cancer Cell|November 12, 2015
SnapShot: Multiple MyelomaEsteban Braggio, K Martin Kortüm, A Keith Stewart
Cancer Research|October 2, 2023
A Landmark Paper That Introduced Proteasome Inhibition in MyelomaAnup Joseph Devasia, Guido Lancman, A Keith Stewart
Leukemia & Lymphoma|September 13, 2012
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myelomaYuan Xiao Zhu, K Martin Kortuem, A Keith Stewart
Hematology/Oncology Clinics of North America|January 3, 2024
Management of Newly Diagnosed Multiple Myeloma Today, and in the FutureAnup Joseph Devasia, Guido Sebastian Lancman, Alexander Keith Stewart
British Journal of Haematology|October 20, 2004
Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletionsHong Chang, Stephen Sloan, Dan Li, et al.
Acta Biochimica Et Biophysica Sinica|December 31, 2013
Mechanism of immunomodulatory drugs' action in the treatment of multiple myelomaXiubao Chang, Yuanxiao Zhu, Changxin Shi, et al.
Current Hematology Reports|December 30, 2003
Insights from the gene expression profiling of multiple myelomaJaime O Claudio, Esther Masih-Khan, A Keith Stewart
Blood|October 29, 2009
How I treat multiple myeloma in younger patientsA Keith Stewart, Paul G Richardson, Jesus F San-Miguel
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Future Oncology (London, England)|May 17, 2011
Carfilzomib: a novel second-generation proteasome inhibitorMeaghan L Khan, A Keith Stewart
International Journal of Biochemistry and Molecular Biology|October 18, 2011
What is the functional role of the thalidomide binding protein cereblon?Xiu-Bao Chang, A Keith Stewart
Cancer Cell|November 12, 2015
SnapShot: Multiple MyelomaEsteban Braggio, K Martin Kortüm, A Keith Stewart
Cancer Research|October 2, 2023
A Landmark Paper That Introduced Proteasome Inhibition in MyelomaAnup Joseph Devasia, Guido Lancman, A Keith Stewart
Leukemia & Lymphoma|September 13, 2012
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myelomaYuan Xiao Zhu, K Martin Kortuem, A Keith Stewart
Hematology/Oncology Clinics of North America|January 3, 2024
Management of Newly Diagnosed Multiple Myeloma Today, and in the FutureAnup Joseph Devasia, Guido Sebastian Lancman, Alexander Keith Stewart
British Journal of Haematology|October 20, 2004
Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletionsHong Chang, Stephen Sloan, Dan Li, et al.
Acta Biochimica Et Biophysica Sinica|December 31, 2013
Mechanism of immunomodulatory drugs' action in the treatment of multiple myelomaXiubao Chang, Yuanxiao Zhu, Changxin Shi, et al.
Current Hematology Reports|December 30, 2003
Insights from the gene expression profiling of multiple myelomaJaime O Claudio, Esther Masih-Khan, A Keith Stewart
Blood|October 29, 2009
How I treat multiple myeloma in younger patientsA Keith Stewart, Paul G Richardson, Jesus F San-Miguel
Pageof 21